May 2006
Volume 47, Issue 13
ARVO Annual Meeting Abstract  |   May 2006
The Effect Of Mitomycin–C On Keratocytes: An In Vitro Study
Author Affiliations & Notes
  • D.H. Lee
    Ophthalmology, Duke, Durham, NC
  • T. Kim
    Ophthalmology, Duke, Durham, NC
  • Footnotes
    Commercial Relationships  D.H. Lee, None; T. Kim, None.
  • Footnotes
    Support  RPB grant
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 2987. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      D.H. Lee, T. Kim; The Effect Of Mitomycin–C On Keratocytes: An In Vitro Study . Invest. Ophthalmol. Vis. Sci. 2006;47(13):2987.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : Mitomycin–C (MM–C) is a potent alkylating agent that cross links DNA and inhibits keratocyte proliferation. It is used to treatin the treatment of corneal haze after refractive surgery and and to prevent haze in primary surface ablation procedurescases. There has been no known complications associated with in ccorneal applications thus so far. However, the But long– term safety of MM–C still needs to be addressedshould be answered. The purpose of this study is to evaluate the long term effect of MM–CMitomycin–C on keratocytes of different species.

Methods: : Primary keratocytes from porcine, chicken, human and rabbit corneas were cultured in DMEM media with 10% FBS after overnight digestion with collagenase and hyaluronidase. Keratocytes between 3rd and 5th passages were used. They were treated with 0.01%, 0.001%, and 0.0001% of mMitomycin–c solution for 100 minutes. The cell toxicity was measured using flow cytometric analysis after staining with aAnnexin V–FITC and pPropidium iIodide. Cell proliferation was assessed by MTT (dimethylthiazol diphenyl tetrazolium bromide) assay.

Results: : MTT assay showed that cell proliferation reduced to 32%, 12% and 10% in 0.01%, 0.001%, 0.0001% MMC solution treatment respectively. Flow cytometric analysis with annexin V–FITC /PI staining showed increased early apoptosis only in the 0.01% concentration groupof 0.01% , and there were no significant differences between other concentrations. There were nNo differences in late apoptosis were observed.

Conclusions: : This study revealed that mMitomycin–C 0.01% shows keratocytecell toxicity in 0.01% and causes early apoptosis in vitro.

Keywords: cornea: clinical science • cornea: stroma and keratocytes • cell survival 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.